1[2]Cook JL, Kreeger JM, Payne JT, et al. Three-dimensional culture of canine articular chondrocyte on multiple transplantable substrates. Am J Vet Res 1997;58:419 - 24
2[3]James LC, Collins A, John MK, et al. Effects of human recombinant interleukin-lβon canine articular chondrocytes in three-dimensional culture. AJVR 2000;61:766 -70
3[4]Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs. Oxford University Press. Oxford UK 2000 ;203 - 10
4[6]Han Z, Boyle DL, Aupperle KR, et al. Jun N-terminal Kinase inrheumatoidarthritis. J Pharm Exp Therapeutics 1999;291: 124- 30
5[7]Bresnihan B, Phillips FM, Draganich LF, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; (41): 2196 -204
6[8]Lark IM, Rowan, AD, Cawston, et al. Matrix metalloprotein inhibitor in the treatment of arthritis. Curr Opin Anti-inflammatory Immunomodulatory Drug 2000;2:16 -25
7T. T. Chowdhury,D. M. Salter,D. L. Bader,D. A. Lee.Signal transduction pathways involving p38 MAPK, JNK, NFκB and AP-1 influences the response of chondrocytes cultured in agarose constructs to IL-1β and dynamic compression[J].Inflammation Research.2008(7)
8Murata M,Yudo K,Nakamura H,et al.Hypoxia upregulates the expression of angiopoietin-Like-4in human articular chondrocytes:role of angiopoietin-Like-4in the expression of matrix metalloproteinases and cartilage degradation[].Journal of Orthopaedic Research.2009
9Richette P,Francois M,Vicaut E,et al.A high interleukin1receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis[].Rheumatology.2008
10Baltzer AWA,Moser C,Jansen SA,et al.Autologous conditioned serum(Orthokine)is an effective treat ment for knee osteoarthritis[].Osteoarthritis and Cartilage.2009
10Yousef AA,Amr YM,Suliman GA. The diagnostic value of serum lep-tin monitoring and its correlation with tumor necrosis factor-alpha incritically ill patients:a prospective observational study [ J] . Crit Care,2010,14(2) :R33.
